Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
F420 biosynthesis enzyme
Overview
| Candidate |
| L377R | - | - | - | Delamanid | Reslit | Candidate |
| N32S | - | - | Mycobacterium tuberculosis | Delamanid | Reslit | Candidate |
| G604C | - | - | - | Delamanid | Reslit | Candidate |
| W719G | - | - | - | Delamanid | Reslit | Candidate |
| P843A | - | - | Mycobacterium tuberculosis | Delamanid | Reslit | Candidate |
| H722R | - | - | Mycobacterium tuberculosis | Pretomanid|Delamanid | Reslit | Candidate |
| Y29* | - | - | Mycobacterium tuberculosis | Pretomanid | Reslit | Candidate |
| R563L | - | Mycobacterium tuberculosis | Delamanid | Reslit | Candidate |
| E598Q | - | - | - | Delamanid | Reslit | Candidate |
| H698D | - | - | - | Delamanid | Reslit | Candidate |
| G258D | - | - | - | Delamanid | Reslit | Candidate |
| T89S | - | Mycobacterium tuberculosis | Delamanid | Reslit | Candidate |
| Q58* | - | - | Pretomanid | Reslit | Candidate |
| W27* | - | - | Pretomanid | Reslit | Candidate |
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.
This study identifies numerous mutations in genes associated with resistance to bedaquiline, clofazimine, linezolid, delamanid, and pretomanid in Mycobacterium tuberculosis, highlighting the genetic basis of resistance to these drugs.
Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil.
The study identified multiple AMR genes and mutations in Mycobacterium tuberculosis variant bovis strains from Mato Grosso, Brazil, including resistance to pyrazinamide, isoniazid, rifampicin, streptomycin, ethambutol, ethionamide, fluoroquinolones, kanamycin, capreomycin, paraminosalicylic acid, cycloserine, bedaquiline, linezolid, and delamanid.
Selection of Multi-Drug Targets against Drug-Resistant Mycobacterium tuberculosis XDR1219 Using the Hyperbolic Mapping of the Protein Interaction Network.
The study identifies several drug targets (DTs) in Mycobacterium tuberculosis XDR1219 using hyperbolic mapping of the protein interaction network. Key DTs include rpsA, rpsL, embB, embA, fbiC, fbiB, rpoB, dnaK, rpoA, rpoC, rpoZ, ddl, alr, pbpB, rplD, rplC, rmlC, Isr2, tlyA, pknB, dprE1, fas, accD1, accE5, Rv0200, galE3, pks5, msl3, phoP, dacB2, pknI, echA19, ltp3, and Rv3520c, which are involved in various metabolic pathways and are targeted by different antibiotics.
Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing.
The study identified multiple AMR genes and mutations in Mycobacterium bovis isolates, including resistance to isoniazid, streptomycin, ethambutol, fluoroquinolones, pyrazinamide, d-cycloserine, rifampin, delamanid, and para-aminosalicylic acid.
Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran.
This study identified multiple mutations in the fgd1, fbiA, fbiC, rplC, and rrl genes associated with delamanid and linezolid resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Iran.
In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research